| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/31/1994 | EP0612241A1 Ionic beads useful for controlled release and adsorption |
| 08/31/1994 | EP0612240A1 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 08/31/1994 | EP0374257B1 STABLE INTERFERON $g(b) COMPOSITION |
| 08/31/1994 | CN1091470A Unreductases produced of saccharide preparation and application of same |
| 08/31/1994 | CN1091317A Improved topical delivery of drugs |
| 08/31/1994 | CN1091314A Pharmaceutical compositions containing a calcitonin |
| 08/30/1994 | US5342940 Reacting with cyanuric chloride; modified proteins |
| 08/30/1994 | US5342924 Extracellular segments of human ε immunoglobulin anchoring peptides and antibodies specific therefor |
| 08/30/1994 | US5342770 Conjugate including a sugar and peptide linker |
| 08/30/1994 | US5342764 Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein |
| 08/30/1994 | US5342627 Controlled release device |
| 08/30/1994 | US5342626 Gum blend of gellan, carrageenan, mannan gums, gelling salt |
| 08/30/1994 | US5342620 Use of borate-polyol complexes in ophthalmic compositions |
| 08/30/1994 | US5342612 Potentiating or safening amount of aqueous surfactant with tumor necrosis factor |
| 08/30/1994 | US5342609 Purification, filtration; for use in MRI |
| 08/30/1994 | US5342605 Polymeric X-ray compositions containing iodinated polymeric beads |
| 08/30/1994 | CA1331740C Slow release preparation of diltiazem, and a medicine provided thereby |
| 08/30/1994 | CA1331739C Dosage form comprising parallel laminae |
| 08/26/1994 | CA2106519A1 Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin |
| 08/24/1994 | EP0611573A2 Bioactive conjugates of cellulose with amino compounds |
| 08/24/1994 | EP0611572A2 Process to prepare a cetrorelix lyophilised composition |
| 08/24/1994 | EP0611567A1 Ultrafine powder for inhalation and production thereof |
| 08/24/1994 | EP0611376A1 Production and use of multimeric hemoglobins |
| 08/24/1994 | EP0611326A1 Method for producing nanocapsules with cross-linked protein-based walls, nanocapsules thereby obtained, and cosmetic, pharmaceutical and food compositions using same. |
| 08/24/1994 | EP0611306A1 Hemoglobins as drug delivery agents |
| 08/24/1994 | EP0611305A1 Stabilization of human interferon |
| 08/24/1994 | EP0611303A1 PREPARATIONS CONTAINING Carboplatin or Lobaplatin FOR ANTI-TUMOUR THERAPY AND/ OR STIMULATING THE HAEMATOPOIETIC SYSTEM |
| 08/24/1994 | EP0521057B1 Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | EP0414688B1 Process for regulating the absorption rate of drugs and a pharmaceutical formulation |
| 08/24/1994 | CN1091030A Drug for eliminating fishbone in throat and its preparation method |
| 08/24/1994 | CN1091004A Hydrogel slow-releasing agent |
| 08/23/1994 | US5340849 A drug delivery by injecting a liquid blends of an acrylic ester terminated prepolymer, curing agent, active drugs into body cavity, stimulating the crosslinking by body fluid |
| 08/23/1994 | US5340803 Method and compositions for treating tumors having high tyrosinase activity |
| 08/23/1994 | US5340732 Antiviral protein |
| 08/23/1994 | US5340614 Utilizing supercritical fluid with selected additives |
| 08/23/1994 | US5340591 Heating drug with water soluble polymers |
| 08/23/1994 | US5340589 Antiandrogenic steroids |
| 08/23/1994 | US5340574 Stabilized non-glycosylated recombinant human IL2 in reduced form compositions |
| 08/23/1994 | US5340572 Alkaline ophthalmic suspensions |
| 08/23/1994 | CA1331559C Antimicrobial preservative compositions and methods |
| 08/19/1994 | CA2115815A1 Pharmaceutical compositions |
| 08/18/1994 | WO1994018332A2 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | WO1994018317A1 Regulated transcription of targeted genes and other biological events |
| 08/18/1994 | WO1994018264A1 Methods of polymer impregnation |
| 08/18/1994 | WO1994018247A1 Azlactone activated polyalkylene oxides |
| 08/18/1994 | WO1994017831A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/18/1994 | WO1994017830A1 Cosmetic compositions |
| 08/18/1994 | WO1994017827A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/18/1994 | WO1994017819A1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 08/18/1994 | WO1994017811A1 Wound-healing compositions containing iodine and a non-reducing sugar |
| 08/18/1994 | WO1994017808A1 Process to prepare pharmaceutical compositions containing vecuronium bromide |
| 08/18/1994 | WO1994017802A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
| 08/18/1994 | WO1994017801A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
| 08/18/1994 | WO1994017792A2 Compositions and methods for transdermal drug delivery |
| 08/18/1994 | WO1994017785A1 Alkaline ophthalmic suspensions |
| 08/18/1994 | WO1994017676A1 Starch hydrolysates as sequesterers |
| 08/18/1994 | WO1994017675A1 Taste modifying method and bitter taste reducing method |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | CA2156084A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/18/1994 | CA2155848A1 Wound-healing ccompositions containing iodine and a non-reducing sugar |
| 08/18/1994 | CA2155514A1 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | CA2155179A1 Alkaline ophthalmic suspensions |
| 08/18/1994 | CA2154359A1 Methods of polymer impregnation |
| 08/18/1994 | CA2153243A1 Compositions and methods for transdermal drug delivery |
| 08/18/1994 | CA2150373A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
| 08/18/1994 | CA2150135A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
| 08/18/1994 | CA2117889A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/17/1994 | EP0611207A1 Process for stabilisation of vesicles of amphiphilic lipids and composition for topical application containing these stabilized vesicles |
| 08/17/1994 | EP0610655A1 Medicament containing dexpanthenol for topical application |
| 08/17/1994 | EP0610595A2 Composition of l-dopa esters |
| 08/17/1994 | EP0610502A1 Emulsion containing parathyroid hormone for pernasal administration |
| 08/17/1994 | EP0610481A1 Extraction of collagen |
| 08/17/1994 | EP0610445A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 08/17/1994 | EP0610441A1 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
| 08/17/1994 | EP0610356A1 Diagnosis and treatment of bacterial dysentery |
| 08/17/1994 | EP0610351A1 New drug formulations with ion-exchangers |
| 08/17/1994 | EP0610333A1 Treated apatite particles for medical diagnostic imaging |
| 08/17/1994 | EP0610295A1 Lipophilic oligosaccharide antibiotic salt compositions |
| 08/17/1994 | EP0610289A1 Formation of stable liposomes from lipid extracts of archaeobacteria (archaea). |
| 08/17/1994 | EP0610232A1 Synthetic transfection vectors |
| 08/17/1994 | EP0451215B1 Pulmonary administration of pharmaceutically active substances |
| 08/17/1994 | EP0391909B1 Ocular cyclosporin composition |
| 08/17/1994 | EP0274498B2 Medicaments with delayed release of active ingredient |
| 08/17/1994 | CN1090773A Preparation for keeping living pulpa dentis to treat pulpitis |
| 08/17/1994 | CA2089635A1 Treatment of disease employing hyaluronic acid and nsaids |
| 08/17/1994 | CA2089621A1 Formulations containing hyaluronic acid |
| 08/16/1994 | US5338837 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| 08/16/1994 | US5338732 Megestrol acetate formulation |
| 08/16/1994 | US5338669 Transfecting ligated nucleic acid into eukaryotic host cell; culturing |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/16/1994 | US5338533 Controlled release device, and method of preparation |
| 08/16/1994 | US5338532 Starburst conjugates |
| 08/16/1994 | CA2115630A1 Bioactive conjugates of cellulose with amino compounds |
| 08/16/1994 | CA1331447C Health product, in particular for the caring of the teeth of dogs |
| 08/12/1994 | CA2088927A1 Preservative system for vitamin e aqueous solution |
| 08/10/1994 | EP0609968A2 Compositions comprising partial esters of alginic acid |
| 08/10/1994 | EP0609336A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 08/10/1994 | EP0609330A1 Composition for topical application |
| 08/10/1994 | EP0609221A1 Antimicrobial dialdehyde composition and methods of use. |